153 related articles for article (PubMed ID: 26339224)
1. Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology.
Richter H; Dombrowski S; Hamer H; Hadji P; Kostev K
Ger Med Sci; 2015; 13():Doc14. PubMed ID: 26339224
[TBL] [Abstract][Full Text] [Related]
2. German longitudinal prescription database (LRx): Description of characteristics, use in pharmacoepidemiological research, and limitations
.
Kostev K; Wang Y; Singh R; Kalder M; Loosen SH; Roderburg C; Konrad M; Jacob L
Int J Clin Pharmacol Ther; 2024 Jan; 62(1):20-28. PubMed ID: 37969094
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases.
Kapellen TM; Reimann R; Kiess W; Kostev K
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1293-1297. PubMed ID: 27754966
[TBL] [Abstract][Full Text] [Related]
4. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
[TBL] [Abstract][Full Text] [Related]
5. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
6. Treatment persistence in the use of basal insulins in Poland and Germany
.
Rathmann W; Czech M; Franek E; Kostev K
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
[TBL] [Abstract][Full Text] [Related]
7. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database.
Hsia Y; Neubert AC; Rani F; Viner RM; Hindmarsh PC; Wong IC
Br J Clin Pharmacol; 2009 Feb; 67(2):242-9. PubMed ID: 19260863
[TBL] [Abstract][Full Text] [Related]
8. Templates for analysis of individual-level prescription data.
Hallas J; Støvring H
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):260-5. PubMed ID: 16611200
[TBL] [Abstract][Full Text] [Related]
9. Prescription of insulin glargine in primary care practices in Germany.
Rathmann W; Haastert B; Riebel P; Schroeder-Bernhardi D; Kostev K; Huppertz E; Giani G
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):252-6. PubMed ID: 17479442
[TBL] [Abstract][Full Text] [Related]
10. [Changes in features of diabetes care in Hungary in the period of years 2001-2014. Aims and methods of the database analysis of the National Health Insurance Fund].
Jermendy G; Kempler P; Abonyi-Tóth Z; Rokszin G; Wittmann I
Orv Hetil; 2016 Aug; 157(32):1259-65. PubMed ID: 27499284
[TBL] [Abstract][Full Text] [Related]
11. [Regional analysis of drug treatment prevalence and medication of diabetes mellitus in Germany].
Willert T; Walker J; Schramm W
Dtsch Med Wochenschr; 2012 Nov; 137(46):2363-8. PubMed ID: 23132154
[TBL] [Abstract][Full Text] [Related]
12. Utilization of drug sales data for the epidemiology of chronic diseases: the example of diabetes. The EURODIAB Subarea C Study Group.
Papoz L
Epidemiology; 1993 Sep; 4(5):421-7. PubMed ID: 8399690
[TBL] [Abstract][Full Text] [Related]
13. Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005.
Savica R; Beghi E; Mazzaglia G; Innocenti F; Brignoli O; Cricelli C; Caputi AP; Musolino R; Spina E; Trifirò G
Eur J Neurol; 2007 Dec; 14(12):1317-21. PubMed ID: 17903210
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
Heinze G; Jandeck LM; Hronsky M; Reichardt B; Baumgärtel C; Bucsics A; Müllner M; Winkelmayer WC
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
[TBL] [Abstract][Full Text] [Related]
15. Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs.
Dörks M; Langner I; Timmer A; Garbe E
Epilepsy Res; 2013 Jan; 103(1):45-53. PubMed ID: 22795320
[TBL] [Abstract][Full Text] [Related]
16. Data safety and drug safety in Germany: a closing gap?
Rathmann W
Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):625-30. PubMed ID: 11980251
[TBL] [Abstract][Full Text] [Related]
17. [A pharmacoepidemiological study of antiepileptic drug consumption (1992-2004)].
Abasolo-Osinaga E; Abecia-Inchaurregui LC; Etxeandia-Ikobaltzeta I; Burgos-Alonso N; García-del Pozo J
Rev Neurol; 2008 Apr 16-30; 46(8):449-53. PubMed ID: 18428100
[TBL] [Abstract][Full Text] [Related]
18. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
[TBL] [Abstract][Full Text] [Related]
19. Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005.
Alacqua M; Trifirò G; Spina E; Moretti S; Tari DU; Bramanti P; Caputi AP; Arcoraci V
Epilepsy Res; 2009 Jul; 85(1):107-13. PubMed ID: 19345564
[TBL] [Abstract][Full Text] [Related]
20. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database.
Støvring H; Andersen M; Beck-Nielsen H; Green A; Vach W
Lancet; 2003 Aug; 362(9383):537-8. PubMed ID: 12932388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
